Instanosis, Inc.
Test Smarter. Act Faster. Save Lives.
Milford, United States · Founded 2022
- Headquarters
- Milford, Delaware
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- instanosis.com
- Last Round
- GrantJan 2024
- Rounds
- 1
About
Instanosis is a biotech diagnostics company developing CLIA-waived, FDA-cleared rapid drug detection tools for hospitals, harm reduction organizations, and forensic teams. The company manufactures lateral flow immunoassay diagnostics for detecting fentanyl, xylazine, nitazenes, and other drugs without requiring laboratory infrastructure. Instanosis serves healthcare systems, emergency responders, and forensic investigators with US-manufactured diagnostic products.
Summary
Instanosis, Inc. is a Biotech company based in Milford, United States, founded in 2022. Its most recent funding was a Grant round in Jan 2024. Investors include National Institutes of Health.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2024
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/instanosis-inc"><img src="https://indexed.vc/api/badge/company/instanosis-inc" alt="Instanosis, Inc. on Indexed.vc" width="260" height="76" /></a>